Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04274192 · ClinicalTrials.gov registry record · NA
Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04274192: Clinical Trial NA study, sponsored by University of Arkansas.
NCT04274192 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04274192, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Patients will be randomized to begin the study with either NAVA-synchronized or continuous HFNC. Each patient will receive two 15-minute trials at different levels of continuous HFNC and two 15-minute trials at corresponding levels of synchronized HFNC. In synchronized HFNC, using the NIV NAVA mode on the ventilator each subject will receive a constant minimum flow, but with each neurally triggered breath (as measured with an Edi catheter), an additional flow will be given to the patient. This differs from continuous HFNC in which the subject receives a constant flow without variation. Subjects will be observed during the entirety of these trials. Values for the primary and secondary outcomes will be monitored, recorded, and calculated.
Primary Outcome
estimated using swing Edi
Interventions
- OTHER Synchronized HFNC at 6 liters per minute (LPM)
- OTHER Continuous HFNC at 6 liters per minute (LPM)
- OTHER Synchronized HFNC at 8 liters per minute (LPM)
- OTHER Continuous HFNC at 8 liters per minute (LPM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2021-01-28 |
| Phase | NA |
Why NCT04274192 stopped before completion
NCT04274192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Synchronized HFNC at 6 liters per minute (LPM) is the first listed.
NCT04274192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04274192 about?
NCT04274192 is a clinical study titled "Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD". Patients will be randomized to begin the study with either NAVA-synchronized or continuous HFNC. Each patient will receive two 15-minute trials at different levels of continuous HFNC and two 15-minute trials at corresponding levels of synchronized HFNC. In synchronized HFNC, using the NIV NAVA mode ...
What is the current status of trial NCT04274192?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2020-12-09. Estimated completion is 2021-01-28.
What interventions are being tested in trial NCT04274192?
The interventions under investigation include: Synchronized HFNC at 6 liters per minute (LPM) (OTHER), Continuous HFNC at 6 liters per minute (LPM) (OTHER), Synchronized HFNC at 8 liters per minute (LPM) (OTHER), Continuous HFNC at 8 liters per minute (LPM) (OTHER).
Who is sponsoring clinical trial NCT04274192?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04274192's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI